\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Digital, Industry & SpaceAs part of its bigger aim to boost the EU’s competitiveness and growth and drive the green transition, the programme is offering new opportunities.
The 13 topics under the Call “Climate Neutral, Circular and Digitised Production 2022” (Cluster 4 - Destination 'Climate neutral, circular and digitised production') open on 12 October 2021 and close on 30 March 2022 17:00 (CEST). The total budget is €334.5 million.
The 22 topics under the Call “A Digitised, Resource-Efficient and Resilient Industry 2022” (Cluster 4 - Destination 'Increased autonomy in key strategic value chains for resilient industry') open on 12 October 2021 and close on 30 March 2022 17:00 (CEST). The total budget is €402.2 million.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
